These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11034112)

  • 1. Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy.
    Cagnacci A; Arangino S; Angiolucci M; Melis GB; Tarquini R; Renzi A; Volpe A
    J Pineal Res; 2000 Oct; 29(3):152-8. PubMed ID: 11034112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy.
    Cagnacci A; Arangino S; Angiolucci M; Melis GB; Facchinetti F; Malmusi S; Volpe A
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):261-6. PubMed ID: 11207642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement.
    Cagnacci A; Zanni AL; Veneri MG; Menozzi R; Volpe A; Rio GD
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):367-72. PubMed ID: 10971455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study.
    Penotti M; Farina M; Castiglioni E; Gaffuri B; Barletta L; Gabrielli L; Vignali M
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):606-11. PubMed ID: 8828422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women.
    De Leo V; la Marca A; Orlandi R; Crippa D; Setacci C; Petraglia F
    Maturitas; 2003 Nov; 46(3):219-24. PubMed ID: 14585525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients.
    Persico N; Mancini F; Artini PG; de Iaco P; Volpe A; de Aloysio D; Battaglia C
    Ultrasound Obstet Gynecol; 2005 Oct; 26(5):546-51. PubMed ID: 16184506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy.
    Penotti M; Nencioni T; Gabrielli L; Farina M; Castiglioni E; Polvani F
    Am J Obstet Gynecol; 1993 Nov; 169(5):1226-32. PubMed ID: 8238189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy.
    Battaglia C; Regnani G; Artini PG; Genazzani AR; Primavera MR; Salvatori M; Volpe A
    Gynecol Endocrinol; 1999 Aug; 13(4):223-9. PubMed ID: 10533156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: a randomized pilot study.
    Wender MC; Vigo F; Oliveira PP; Bittellbrun F; Furtado AP; Schvartzman L; Capp E; de Freitas FM
    J Obstet Gynaecol Res; 2011 Jul; 37(7):815-8. PubMed ID: 21410828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy.
    Di Carlo C; Tommaselli GA; Pisano G; Nasti A; Rossi V; Palomba S; Nappi C
    Menopause; 2000; 7(1):36-41. PubMed ID: 10646702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study.
    Huang CY; Fu CY; Tseng JY; Yang TS; Chao KC
    Taiwan J Obstet Gynecol; 2009 Mar; 48(1):60-4. PubMed ID: 19346194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
    Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
    JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index.
    Jackson S; Vyas S
    Br J Obstet Gynaecol; 1998 Apr; 105(4):408-12. PubMed ID: 9609267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.